Cargando…

Presence of Antigen-Experienced T Cells with Low Grade of Differentiation and Proliferative Potential in Chronic Chagas Disease Myocarditis

BACKGROUND: The main consequence of chronic Trypanosoma cruzi infection is the development of myocarditis in approximately 20–30% of infected individuals but not until 10–20 years after the initial infection. We have previously shown that circulating interferon-γ-secreting T cells responsive to Tryp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Argüello, Rafael J., Vigliano, Carlos, Cabeza-Meckert, Patricia, Viotti, Rodolfo, Garelli, Fernando, Favaloro, Liliana E., Favaloro, Roberto R., Laguens, Rubén, Laucella, Susana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140664/ https://www.ncbi.nlm.nih.gov/pubmed/25144227 http://dx.doi.org/10.1371/journal.pntd.0002989

Ejemplares similares

Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease
por: Argüello, Rafael J., et al.
Publicado: (2012)

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease
por: Viotti, Rodolfo, et al.
Publicado: (2011)

Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole
por: Castro Eiro, Melisa D., et al.
Publicado: (2022)

Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease
por: Pengue, Claudia, et al.
Publicado: (2019)

Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy
por: Pérez-Mazliah, Damián E., et al.
Publicado: (2018)

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
por: Albareda, María Cecilia, et al.
Publicado: (2015)

The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects
por: Castro Eiro, Melisa D., et al.
Publicado: (2017)

Chagas Disease and the London Declaration on Neglected Tropical Diseases
por: Tarleton, Rick L., et al.
Publicado: (2014)

Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease
por: Caputo, María Belén, et al.
Publicado: (2022)

Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients
por: Duffy, Tomas, et al.
Publicado: (2009)

Anatomopathological Aspects of Acute Chagas Myocarditis by Oral Transmission
por: de Souza, Dilma do Socorro Moraes, et al.
Publicado: (2016)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: reflections based on recent contemporary test data
por: Favaloro, Emmanuel J.
Publicado: (2022)

Comparing the quality of testing for von Willebrand disease in different geographic localities
por: Favaloro, Emmanuel J.
Publicado: (2022)

To Clot or Not to Clot: Is That the Question?
por: Favaloro, Emmanuel J.
Publicado: (2023)

Letter in response to Colpani et al “A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”
por: Favaloro, Emmanuel J.
Publicado: (2023)

MORPHOMETRIC STUDY OF MYOCARDIAL MITOCHONDRIA IN THE RAT
por: Laguens, Ruben
Publicado: (1971)

Status and development of allied health personnel in cardiothoracic surgery in Latin America
por: Bertolotti, A, et al.
Publicado: (2011)

The new oral anticoagulants and the future of haemostasis laboratory testing
por: Favaloro, Emmanuel J, et al.
Publicado: (2012)

D-dimer measurement in COVID-19: Silver bullet or clinical distraction?
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Variability in D-dimer reporting revisited
por: Favaloro, Emmanuel J., et al.
Publicado: (2021)

2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines
por: Othman, Maha, et al.
Publicado: (2021)

Should multiple factor dilutions be performed for all patient coagulation factor assays? Let the debate begin!
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources
por: Favaloro, Emmanuel J., et al.
Publicado: (2023)

Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et al
por: Favaloro, Emmanuel J., et al.
Publicado: (2023)

Allopurinol reduces antigen-specific and polyclonal activation of human T cells
por: Pérez-Mazliah, Damián, et al.
Publicado: (2012)

Molecular Remodeling of Cardiac Sinus Node Associated with Acute Chagas Disease Myocarditis
por: Rodríguez-Angulo, Héctor O., et al.
Publicado: (2021)

The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?
por: Favaloro, Emmanuel J., et al.
Publicado: (2010)

Why Do Patients Bleed?
por: Curnow, Jennifer, et al.
Publicado: (2016)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
por: Reardon, Benjamin, et al.
Publicado: (2021)

Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

How often are parenteral anticoagulants administered by parents?
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Autoimmune Diseases Affecting Hemostasis: A Narrative Review
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption
por: Štambuk, Sandra Karanović, et al.
Publicado: (2023)

Diagnostic Features of Acute Chagas Myocarditis with Sudden Death in a Family of Boxer Dogs
por: Vitt, J.P., et al.
Publicado: (2016)

Myocardial Edema without Fibrosis by Magnetic Resonance T2 Mapping in Acute Chagas’ Myocarditis
por: de Sousa, Andréa Silvestre, et al.
Publicado: (2017)

Death due to acute Chagas -related myocarditis in a child: a case report
por: da Silva, Theresa Cristina Cardoso, et al.
Publicado: (2020)

Biomedical research platforms and their influence on article submissions and journal rankings: An update.
por: Lippi, Giuseppe, et al.
Publicado: (2012)

The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
por: Colonne, Chanukya K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5us01n55o3t6m8tqkinfa61dr0